Intra-oral snoring devices may be acceptable for OTC sale -- FDA Dental Products Panel.
This article was originally published in The Tan Sheet
Executive Summary
INTRA-ORAL SNORING DEVICES OTC AVAILABILITY MAY BE ACCEPTABLE with appropriate safety and efficacy data, members of FDA's Dental Products Panel said at a Nov. 5 meeting in Bethesda, Md. Responding to FDA's request for general input on the possibility of over-the-counter sale of intra-oral devices for treatment of snoring and sleep apnea, most panel members felt OTC labeling for treatment of snoring, but not sleep apnea, might be conceivable.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning